← Leaderboards
Sara J Buhrlage
Dana-Farber Cancer Inst
$3,075,632
Attributed
$4,631,109
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2017–22$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$4,631,109 · 3
By mechanism
R01$3,983,289 · 2
R21$647,820 · 1
Top collaborators
- Jarrod A. Marto6 shared
Most similar at Dana-Farber Cancer Inst
Same institution · by research overlap
- Jarrod A. Marto$4,866,870
- Peter M Howley$39,809,224
Others in their field
Other Emerging Leaders on “Enzymes”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$143,577,666
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Jacob Ruff · Cornell University$22,500,000
- Elke Arenholz · Cornell University$14,750,000
- Sacha Gnjatic · Icahn School Of Medicine At Mount Sinai$14,335,772
- Amitinder Kaur · Tulane University Of Louisiana$12,771,713
Research focus
EnzymesDrug TargetingDesignStructureMalignant NeoplasmsEnzyme ActivityProteomicsUbiquitinCellsBiologyLeadInhibitor/AntagonistAnimal ModelBaseDoseDeubiquitinating EnzymeCollectionCell PhysiologyFamilyFutureChemoproteomicsBiochemicalEnzyme Inhibitor DrugsBinding
Grant awards (9)
Novel Screening Platform for Discovery of DUB Targeting Probes$591,626
R01 · FY2022 · CA · contact PI
Novel Screening Platform for Discovery of DUB Targeting Probes$610,908
R01 · FY2021 · CA · contact PI
Tools for DUB Drug Discovery$323,910
R21 · FY2021 · CA
Novel Screening Platform for Discovery of DUB Targeting Probes$630,805
R01 · FY2020 · CA · contact PI
Tools for DUB Drug Discovery$323,910
R21 · FY2020 · CA
Novel Screening Platform for Discovery of DUB Targeting Probes$629,796
R01 · FY2019 · CA · contact PI
USP7 inhibitors for the treatment of multiple myeloma$510,712
R01 · FY2019 · CA · contact PI
USP7 inhibitors for the treatment of multiple myeloma$504,721
R01 · FY2018 · CA · contact PI
USP7 inhibitors for the treatment of multiple myeloma$504,721
R01 · FY2017 · CA · contact PI